Daniel Friedmann
Procedural Dermatology · Austin, TXNPI 1326200569
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Abbott at 34.7% of the total. Reporting peaked in 2019 at $55,984 and has fallen 81.6% since, to $10,318 in 2025. Among procedural dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $576.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$51K
- Lumenis, Inc$37K
- AbbVie$26K
- Merz North America, Inc.$20K
- Lumenis BE LTD$3K
- Galderma Laboratories, L.p.$3K
- plus $6K from 14 others
Across 193 payments — averaging $11,876 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2.2M
- Merz North America, Inc.$93K
- E.r. Squibb & Sons, L.L.C.$26K
- LEO Pharma AS$12K
- Bristol Myers Squibb$6K
- Novartis$4K
What the payments were for
- Consulting fees$63,37043%
- Speaking & faculty fees$51,62835%
- Travel & lodging$22,53715%
- Food & beverage$8,7616%
- Education$890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $50,758 |
| Lumenis, Inc | 3 | $37,023 |
| AbbVie(2 entities) | 137 | $25,818 |
| Merz North America, Inc. | 42 | $20,428 |
| Lumenis BE LTD | 2 | $3,300 |
| Galderma Laboratories, L.p. | 19 | $3,161 |
| Lumenis BE Inc | 1 | $3,000 |
| E.r. Squibb & Sons, L.L.C. | 4 | $1,958 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $207 |
| Revance Therapeutics, Inc. | 2 | $190 |
| VYNE Pharmaceuticals Inc. | 1 | $138 |
| Pfizer | 1 | $111 |
| Endo Pharmaceuticals Inc. | 2 | $97 |
| Incyte Corporation | 2 | $62 |
| Sanofi | 1 | $35 |
| Boston Scientific | 1 | $27 |
| LEO Pharma Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $17 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$50,120
- XEOMIN$9,467
- ALLODERM$6,499
- M22$4,800
- Lumenis Pulse 120H$3,000
- BOTOX$2,199
- STRATTICE$600
- BOTOX COSMETIC$388
- Clear & Brilliant$363
- DAXXIFY$140
- AMZEEQ$138
- CIBINQO$111
- Skyrizi$101
How this compares
$146,385 in reported general payments places this provider in the 95th percentile of 25 procedural dermatology providers in Texas.
Other procedural dermatology in Austin
- Daniel LaddAustin$2K
- Liet leKingwood$90K
- Jean-Denis BoucherLive Oak$20K
- Tho NguyenHurst$16K
- Douglas FarrisHurst$16K
- Robert OchsSan Antonio$11K
- Farhad NiroomandDallas$9K
- Laura SearsDallas$8K
- Georganna DavisHouston$8K
- Paige HoyerEl Campo$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.